Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Pittsburgh Article
This is a selection made from among articles on Drug Treatment Pittsburgh. For a permanent link to this article, or to bookmark it for future reading, click here.
New Criminal and Drug Rehab Program Helps a Man Discover his Potentiality
from: Julio was last arrested at 30 years old. Born and raised in Clovis, New Mexico, he moved to Las Vegas, New Mexico, when he was 18, where he graduated High School and then began college. His drug use began recreationally, when a friend showed him the high of sniffing inhalants, gold spray paint. A few years later he was addicted and his attitude in life and his actions had completely changed. Once a good student and a top All State soccer player he flunked out of college. He had lost his dreams.
Years later, he was in Texas and lead a police car on a high speed chase. When they finally popped the tires and then captured Julio he managed to slip out of the hand cuffs. He stole a police car at the scene, and almost ran over a cop in his race to leave the scene. The state tried him for “attempt to commit capital murder on PD”, but fortunately the video showed that he swerved to avoid hitting the officer. Given a five year sentence for getting out of restraint from handcuffs, he did 2.5 years and was paroled in 2005. Julio maintained sobriety through his parole sentence but relapsed and moved back to NM. He lost his wife who went back to Dallas with his second son.
He was rearrested and sentenced for possession of aerosol, misdemeanor attempt to use it for a euphoric feeling. He was busted inhaling behind a housing project in a vacant yard.
Once in the system, again, the social worker for the public defenders office referred him to a new criminal and drug rehabilitation program in Albuquerque, New Mexico. The Second Chance Program was opened by Rick Pendery, who is the national executive director of the Second Chance Centers, after having a high rate of success running the Second Chance Program in state prisons.
Julio has been taking part in the program for six months, he explains what a difference it has made in his life, “Everything has changed. My self confidence is restored, I have self esteem. I no longer see myself as a loser. I have potential to learn, my hunger to get educated has returned. Education is the one thing that can’t be taken away from a person. I want to go back to school. I believe that the best counselor is one who has been through it. I want to help others. I also want to be a soccer coach. And I like to use words, I might want to do something in the field of English literature.”
The Second Chance Program consists of four core modules, the Drug Rehabilitation Module, the Learning Skills Module, the Self Respect Module all of which are delivered in a secure residential facility, on an intensive eight-hour a day, six-day a week course schedule over an average of six to eight months. The Reintegration Module which includes Life Skills is continued post release to ensure their successful reintegration into the community as a productive citizen.
I feel strongly that this program needs to made available to people.”, Julio explains. “I can’t say enough how I feel that it will save lives. That is what it comes down to: Second Chance has become a front line battle for lives out here, the staff here that are willing to pass on what they are being taught are front line soldiers. The drug war is everywhere. We are battling an unseen enemy that is very prevalent. This enemy needs to be addressed. We can’t cover it up. People can’t wait until it affects them or someone they know.”
About Author
Article by Jayden Adams, Editor-in-Chief International Newswire
For more information about the article, go to
Second Chance Program
or
Second Chance Successes
Source: ArticleTrader.com
Drug Treatment Pittsburgh Specific links
Drug Treatment Pittsburgh News
Vertex shares soar on cystic fibrosis drug data
Vertex Pharmaceuticals Inc's new cystic fibrosis drug Kalydeco, when combined with its experimental treatment for the disease, led to significantly improved breathing ability in a mid-stage study, sending ...
Read more...Toxic mushrooms: Drug promises new cure
A investigational drug derived from milk thistle seeds helped save the lives -- and livers -- of four people in the Washington, D.C., area who accidentally ate toxic mushrooms last fall. If approved, it could become standard treatment, experts say.
Read more...Three Abstracts on the ChemoFx® Drug Response Marker Accepted by ASCO
Precision Therapeutics announces that the American Society of Clinical Oncology has accepted three individual abstracts that highlight the utility and feasibility of the ChemoFx® Drug Response Marker for patients with gynecologic sarcomas, cervical cancer and ovarian cancer.
Read more...FDA panel backs Gilead's Truvada to prevent HIV
WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts recommended Gilead Sciences Inc's Truvada as a treatment for preventing HIV infection among people at risk for contracting AIDS, including homosexual and bisexual men. In a move that could lead to a new milestone for treatment in the evolution of the worldwide AIDS epidemic, the FDA advisory committee voted 19-3 ...
Read more...University of Maryland, Baltimore Named New Center of Excellence in Pain Education
NIH Pain Consortium charges 11 health professional institutions, including UMB, with improving education in pain management and treatment.
Read more...Diamyd Medical's Phase II study in cancer pain fully recruited
STOCKHOLM--(BUSINESSWIRE)-- Regulatory News: The last study participant has been recruited to Diamyd Medical’s (STO:DIAMB)(Pink Sheets:DMYDY) Phase II study in which cancer pain is treated with the drug ...
Read more...Addiction Treatment Update
Significant changes are coming to the way Pennsylvania operates drug and alcohol programs. Local supporters of those efforts got an update on the plans on Friday morning.
Read more...Company Profile for Precision Therapeutics, Inc.
Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care. Precision offers a portfolio of products develop
Read more...Mylan Launches Generic Version Of Viramune® Tablets
Mylan Inc. (Nasdaq:MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nevirapine Tablets USP, 200 mg.
Read more...US experts back drug to prevent HIV infection
A UNITED States Food and Drug Administration panel of outside experts has recommended Gilead Sciences Inc's Truvada as a treatment for preventing HIV infection among people at risk for contracting AIDS, including homosexual and bisexual men.
Read more...